Cite
Use of anti-inflammatory drugs and lower esophageal sphincter-relaxing drugs and risk of esophageal and gastric cancers.
MLA
Fortuny, Joan, et al. “Use of Anti-Inflammatory Drugs and Lower Esophageal Sphincter-Relaxing Drugs and Risk of Esophageal and Gastric Cancers.” Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association, vol. 5, no. 10, Oct. 2007, p. 1154. EBSCOhost, https://doi.org/10.1016/j.cgh.2007.05.022.
APA
Fortuny, J., Johnson, C. C., Bohlke, K., Chow, W.-H., Hart, G., Kucera, G., Mujumdar, U., Ownby, D., Wells, K., Yood, M. U., & Engel, L. S. (2007). Use of anti-inflammatory drugs and lower esophageal sphincter-relaxing drugs and risk of esophageal and gastric cancers. Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association, 5(10), 1154. https://doi.org/10.1016/j.cgh.2007.05.022
Chicago
Fortuny, Joan, Christine C Johnson, Kari Bohlke, Wong-Ho Chow, Gene Hart, Gena Kucera, Urvi Mujumdar, et al. 2007. “Use of Anti-Inflammatory Drugs and Lower Esophageal Sphincter-Relaxing Drugs and Risk of Esophageal and Gastric Cancers.” Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association 5 (10): 1154. doi:10.1016/j.cgh.2007.05.022.